Assessment of Interlaboratory Variation in the Immunohistochemical Determination of Estrogen Receptor Status Using a Breast Cancer Tissue Microarray
Open Access
- 1 May 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 117 (5) , 723-728
- https://doi.org/10.1309/pef8-gl6f-ywmc-ag56
Abstract
The determination of tumor cell estrogen receptor (ER) expression status by immunohistochemical analysis has become standard practice, yet assay reprKeywords
This publication has 13 references indexed in Scilit:
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological gradeThe Journal of Pathology, 2001
- Tissue microarray technology for high-throughput molecular profiling of cancerHuman Molecular Genetics, 2001
- Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology?Advances in Anatomic Pathology, 2001
- Validation of Tissue Microarray Technology in Breast CarcinomaLaboratory Investigation, 2000
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999
- Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: Evaluation of discordant findingsBreast Cancer Research and Treatment, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Observer variability in the histopathological reporting of needle biopsy specimens of the prostateHuman Pathology, 1997
- Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methodsBreast Cancer Research and Treatment, 1995
- Immunocytochemical Analysis of Estrogen Receptors in Human Breast CarcinomasArchives of Surgery, 1990